ATE135207T1 - Mittel zur atopieprophylaxe - Google Patents

Mittel zur atopieprophylaxe

Info

Publication number
ATE135207T1
ATE135207T1 AT90105855T AT90105855T ATE135207T1 AT E135207 T1 ATE135207 T1 AT E135207T1 AT 90105855 T AT90105855 T AT 90105855T AT 90105855 T AT90105855 T AT 90105855T AT E135207 T1 ATE135207 T1 AT E135207T1
Authority
AT
Austria
Prior art keywords
pge1
atopy
agent
linolenic acid
hormones
Prior art date
Application number
AT90105855T
Other languages
English (en)
Inventor
B Dr Med Melnik
G Prof Dr Med Plewig
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25879479&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE135207(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE3910761A external-priority patent/DE3910761A1/de
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Application granted granted Critical
Publication of ATE135207T1 publication Critical patent/ATE135207T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Surgical Instruments (AREA)
  • Slot Machines And Peripheral Devices (AREA)
  • Bidet-Like Cleaning Device And Other Flush Toilet Accessories (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90105855T 1989-04-04 1990-03-28 Mittel zur atopieprophylaxe ATE135207T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3910761A DE3910761A1 (de) 1989-04-04 1989-04-04 Mittel zur atopie-prophylaxe
DE3930816 1989-09-14

Publications (1)

Publication Number Publication Date
ATE135207T1 true ATE135207T1 (de) 1996-03-15

Family

ID=25879479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90105855T ATE135207T1 (de) 1989-04-04 1990-03-28 Mittel zur atopieprophylaxe

Country Status (4)

Country Link
EP (1) EP0391218B1 (de)
AT (1) ATE135207T1 (de)
DE (1) DE69025787T2 (de)
DK (1) DK0391218T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3910760A1 (de) * 1989-04-04 1990-10-11 Bodo Dr Med Melnik Neue verwendung bekannter substanzen sowie verfahren zur herstellung von geeigneten praeparaten
CA2030344C (en) * 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5302617A (en) * 1990-04-27 1994-04-12 Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
DK0454429T3 (da) * 1990-04-27 1997-03-17 R Tech Ueno Ltd Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
DE4238869C2 (de) * 1992-11-18 1994-09-08 Wogepharm Gmbh Mittel zur Behandlung des atopischen Ekzems und anderer entzündlicher Hautkrankheiten
US6764693B1 (en) 1992-12-11 2004-07-20 Amaox, Ltd. Free radical quenching composition and a method to increase intracellular and/or extracellular antioxidants
EP0711503A3 (de) * 1994-11-14 1997-11-26 Scotia Holdings Plc Mit GLA und/oder DGLA angereicherte Milch
KR19980701452A (ko) * 1995-01-18 1998-05-15 우에하라 아끼라 피부염 치료제(Remedy for Dermatitis)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
EP0092076B1 (de) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Lipidhaltige Zusammensetzung für die orale, enterale oder parenterale Ernährung
GB2134782B (en) * 1982-09-22 1987-03-04 Sentrachem Ltd Anti-cancer compositions containing higher fatty acids
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US5082664A (en) * 1987-05-22 1992-01-21 The Liposome Company, Inc. Prostaglandin-lipid formulations

Also Published As

Publication number Publication date
EP0391218A3 (de) 1991-09-18
DK0391218T3 (da) 1996-07-29
EP0391218A2 (de) 1990-10-10
DE69025787T2 (de) 1996-10-31
DE69025787D1 (de) 1996-04-18
EP0391218B1 (de) 1996-03-13

Similar Documents

Publication Publication Date Title
ATE135207T1 (de) Mittel zur atopieprophylaxe
GB8819110D0 (en) Antihypertensive drug & method for production
GB8319073D0 (en) Fatty acid compositions
EP0295331A3 (en) Use of vitamin e for normalizing the blood coagulation in the therapy with omega-3-type highly unsaturated fatty acids
NO172389C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler
GR3025178T3 (en) Medicament for the treatment of vulvar dystrophy or vaginal dryness
PL265078A1 (en) A method of new pharmaceutical agents production with a prolonged time of active matter release
HUT47553A (en) Process for producing azitromycin and analogues and pharmaceutical compositions containing them as active components
PH27420A (en) Pharmaceutically active combination composition comprising as components a as plasminogen activator and as component b herein
EP0494405A3 (en) Use of thiazolidine-4-carboxylate derivatives and glutathione esters for the treatment of pulmonary diseases
ATE11014T1 (de) Pharmazeutische und diaetetische zusammensetzung zur erhoehung der serie-l-pg-produktion.
GB8607137D0 (en) Compositions
DE3485337D1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
HUT49808A (en) Process for producing retarde pharmaceutical compositions containing aselastine
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
TW223589B (de)
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
CA2013809A1 (en) Agent for the Prophylaxis of Atopy and Methods for Preparing and Using Same
ATE94062T1 (de) Zubereitungen von essentiellen fettsaeuren zur erhoehung des fettgehaltes von milch von saeugern.
EP0399175A3 (de) PGE1 und Derivate für mukosale oder dermale Anwendung
EP0144489A3 (en) Cerebral and peripheral antihypoxidoticum

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked